title: Persistent reduction of CD4/CD8 lymphocyte ratio and cell activation before the onset of type 1 (insulin-dependent) diabetes.
abstract: Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction.
authors.affiliation: Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, London, UK.
authors.forename: L
authors.initials: L
authors.lastname: Al-Sakkaf
authors.forename: P
authors.initials: P
authors.lastname: Pozzilli
authors.forename: A C
authors.initials: AC
authors.lastname: Tarn
authors.forename: G
authors.initials: G
authors.lastname: Schwarz
authors.forename: E A
authors.initials: EA
authors.lastname: Gale
authors.forename: G F
authors.initials: GF
authors.lastname: Bottazzo
mesh_terms: D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis*; D016827:CD8 Antigens; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology*; D005500:Follow-Up Studies; D006801:Humans; D008213:Lymphocyte Activation; D010641:Phenotype; D011236:Prediabetic State / Q000276:immunology*; D011446:Prospective Studies; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000945:Antigens, Differentiation, T-Lymphocyte; D016827:CD8 Antigens